Epidemiology of small intestinal bacterial overgrowth.
Efremova I, Maslennikov R, Poluektova E, Vasilieva E, Zharikov Y, Suslov A, Letyagina Y, Kozlov E, Levshina A, Ivashkin V.
World J Gastroenterol. 2023 Jun 14;29(22):3400-3421. doi: 10.3748/wjg.v29.i22.3400.
Multidisciplinary management of acromegaly: A consensus.
Giustina A, Barkhoudarian G, Beckers A, Ben-Shlomo A, Biermasz N, Biller B, Boguszewski C, Bolanowski M, Bollerslev J, Bonert V, Bronstein MD, Buchfelder M, Casanueva F, Chanson P, Clemmons D, Fleseriu M, Formenti AM, Freda P, Gadelha M, Geer E, Gurnell M, Heaney AP, Ho KKY, Ioachimescu AG, Lamberts S, Laws E, Losa M, Maffei P, Mamelak A, Mercado M, Molitch M, Mortini P, Pereira AM, Petersenn S, Post K, Puig-Domingo M, Salvatori R, Samson SL, Shimon I, Strasburger C, Swearingen B, Trainer P, Vance ML, Wass J, Wierman ME, Yuen KCJ, Zatelli MC, Melmed S.
Rev Endocr Metab Disord. 2020 Dec;21(4):667-678. doi: 10.1007/s11154-020-09588-z. Epub 2020 Sep 10.
Empty Sella.
Miljic D, Pekic S, Popovic V.
2024 Oct 9. In: Feingold KR, Ahmed SF, Anawalt B, Blackman MR, Boyce A, Chrousos G, Corpas E, de Herder WW, Dhatariya K, Dungan K, Hofland J, Kalra S, Kaltsas G, Kapoor N, Koch C, Kopp P, Korbonits M, Kovacs CS, Kuohung W, Laferrère B, Levy M, McGee EA, McLachlan R, Muzumdar R, Purnell J, Rey R, Sahay R, Shah AS, Singer F, Sperling MA, Stratakis CA, Trence DL, Wilson DP, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000–.
Diabetes in Patients With Acromegaly.
Hannon AM, Thompson CJ, Sherlock M.
Curr Diab Rep. 2017 Feb;17(2):8. doi: 10.1007/s11892-017-0838-7.
Cardiovascular Disorders Associated With Acromegaly: an Update.
Sherin RPV, Vietor NO, Usman A, Hoang TD, Shakir MKM.
Endocr Pract. 2024 Dec;30(12):1212-1219. doi: 10.1016/j.eprac.2024.09.014. Epub 2024 Sep 25.
Prevalence and outcome of comorbidities associated with acromegaly.
Berkmann S, Brun J, Schuetz P, Christ E, Mariani L, Mueller B.
Acta Neurochir (Wien). 2021 Nov;163(11):3171-3180. doi: 10.1007/s00701-021-04846-8. Epub 2021 Apr 15.
Acromegaly is associated with high fibroblast growth factor-21 levels.
Yurekli BS, Kutbay NO, Aksit M, Suner A, Simsir IY, Seckiner S, Kocabas GU, Bozkaya G, Saygili F.
J Endocrinol Invest. 2019 Jan;42(1):53-60. doi: 10.1007/s40618-018-0885-1. Epub 2018 May 12.
Hypertension is Common in Patients with Newly Diagnosed Acromegaly and is Independently Associated with Renal Resistive Index.
Sumbul HE, Koc AS.
High Blood Press Cardiovasc Prev. 2019 Feb;26(1):69-75. doi: 10.1007/s40292-018-0293-9. Epub 2018 Dec 7.
Insulin Resistance in Patients With Acromegaly.
Vila G, Jørgensen JOL, Luger A, Stalla GK.
Front Endocrinol (Lausanne). 2019 Jul 30;10:509. doi: 10.3389/fendo.2019.00509. eCollection 2019.
Presence of cerebral microbleeds is associated with cognitive decline in acromegaly.
Xie Z, Zhuang Y, Zhang Z, Liu J.
Front Oncol. 2022 Nov 24;12:948971. doi: 10.3389/fonc.2022.948971. eCollection 2022.
